Is PI‑RADS upgrading the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI‑RADS‑3 lesions?

  • 0Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran.

|

|

Summary

No abstract available on PubMed